Atlas Trials

ONO-4538 Phase II Rollover Study (ONO-4538-98)

Clinical trial NCT04566380 · RECRUITING

Trial details

NCT number
NCT04566380
Sponsor
Ono Pharmaceutical Co., Ltd.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Pan-tumor
Start date
2020-09-10
Primary completion
2026-12-31
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.